ClinicalTrials.Veeva

Menu

Competing Risk of Death and ESRD in Incident CKD Patients (EPIRAN)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Chronic Kidney Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT03379571
EPIRAN1

Details and patient eligibility

About

Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed.

Methods: From a community-based sample of 4,409 individuals residing in a well-defined geographical area, investigators determined the number of patients having a first serum creatinine value ≥1.7 mg/dL and present for at least 3 months that allowed us to calculate an annual incidence rate of CKD (stages 3 to 5). CKD (stages 3 to 5) was defined by estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. Investigators also described the primary care, outcomes and risk factors associated with outcomes using competing risks analyses for these CKD patients.

Enrollment

631 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >= 18 years
  • first serum creatinine value ≥1.7 mg/dL reached after January 1st, 2004
  • and present for at least 3 months
  • residing in the given geographical area (the Urban Community of Greater Nancy (UCGN))

Exclusion criteria

  • <18 years
  • prevalent CKD patient : CKD diagnosis before January 1st, 2004
  • patients on dialysis or renal transplanted
  • refusal of participation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems